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Successful Liver Transplantation From Crossmatch-
Positive Donors 
S. Iwatsuki, Y. Iwaki, T. Kano, G. Klintmalm, L. J. Koep, R. Weil, and T. E. Starzl 
W E HAVE published before that liver transplantation can be performed suc-
cessfully in spite of positive anti-donor cross-
matches detected with the standard cytotoxic-
ity test.'·2 These so-called positive crossmatch 
cases were compiled before the classification 
of the responsible antibodies3 was possible. 
In the present study, ten previously 
reported recipients whose sera contained anti-
donor cytotoxic antibodies were reviewed. 
The quantity and type of antibodies in the 
recipient sera were determined from their 
reactions to a panel of lymphocyte donors. 
From the results, an educated guess became 
possible as to whether the previous positive 
crossmatches against the organ donors were 
caused by warm anti-T antibodies or by less 
dangerous varieties. 
Finally, a fresh transplant was performed 
in a patient whose preoperative serum 
contained warm anti-T-Iymphocyte antibod-
ies that reacted with heavy killing against the 
liver donor. 
MATERIALS AND METHODS 
In II of 179 cases of orthotopic liver transplantation in 
Denver, the patients received liver homografts from 
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donors to whom the recipients' sera showed strong 
lymphocyte cytotoxic activity by standard cytoxicity 
crossmatch tests. One of the II patients (OT 168) had 
proven strong anti-T- and anti-B-Iymphocyte cytotoxicity 
against the donor. Clinical and pathologic observations of 
these II patients are listed in Table I. 
Pretransplant sera of these II patients were tested for 
anti-T- and anti-B-Iymphocyte antibody under warm and 
cold temperatures against a random lymphocyte panel of 
30-40 donors by a previously reported method.3 Sera 
from the first 10 patients had been stored at -80°C for 
long periods before testing against the lymphocyte panel. 
I n the most recent case (OT 168), the cytotoxicity was 
tested with fresh sera against the organ donor lympho-
cytes as well as against a random lymphocyte panel. 
Immunologic observations in these II patients are 
summarized in Table 2. 
RESULTS 
Immunologic Observation 
Preoperative sera of all 11 patients had 
Iymphocytotoxic antibodies against the spe-
cific donors by standard cytotoxic testing at 
the time of transplantation. In the most recent 
case (OT 168), the pretransplant serum had 
strong anti-T - and anti- B-lymphocytotoxicity 
against the actual liver donor. 
The results of retrospective anti-T - and 
anti-B-Iymphocyte cytotoxicity against a ran-
dom cell panel are shown in Table 2 for all I I 
patients. Excluding the most recent case, OT 
168, whose serum was tested against the 
specific donor cells, five (OT 63, OT 101, OT 
114, OT 119, OT 122) of ten previously 
reported patients possessed strong and wide 
cytotoxic antibody against both T and B 
lymphocytes. Four more (OT 58, OT 71A, 
OT 138, OT 151) had narrow but definite 
antibody against T lymphocyte and wider 
antibody against B lymphocytes. One patient 
(OT 103B) did not have anti-T-Iymphocyte 
antibody against the random cell panel, but 
she had anti-B-Iymphocyte antibody. 
None of the 11 patients had transplanta-
tion across an ABO blood group barrier. 
Transplantation Proceedings, Vol. XIII, No.1 (March). 1981 
LIVER TRANSPLANTATION FROM CROSSMATCH-POSITIVE DONORS 287 
Table 1. Clinical Observation 
OT 
No. Age Sex Diagnosis 
58 34 M Chronic aggressive hepatitis 
63 49 Primary biliary cirrhosis 





Removal at 10 days 
Main Cause of Death 
Refused medication; hepatic insuffi-
ciency 
Gastrointestinal hemorrhage 
Pathologic Changes in Liver 
Resolution of previous obstructive 
changes at 8.5-month biopsy 
(no autopsy) 
Normal liver 
Acute rejection, cellular and hu-
moral 
(Heterograh) 14 days after Pulmonary edema; bronchial hem or- No evidence of cellular rejection; 
retransplantation 
101 28 Primary biliary cirrhosis 189 
114 27 Liver tumor of undetermined type Alive over 4 years 
119 23 M Sclerosing cholangitis 33 
122 28 Chronic aggressive hepatitis 131 
1038 21 Primary biliary cirrhosis 403 
138 42 M Sclerosing cholangitis 108 
151 M Biliary atresia 72 
168 33 Chronic aggressive hepatitis 23 
Clinical and Pathologic Observation 
Despite the probable presence of donor-
specific anti-T -lymphocyte antibody 10 the 
pretransplant sera of at least half of the 
previous ten liver recipients and despite defi-
nite existence of such antibody in the most 
recent recipient (OT 168), hyperacute rejec-
tion such as seen in renal homografts was not 
observed in any case. Early graft dysfunction 
rhage centrilobular cholestasis 
Hepatic insufficiency; renal and cardiac Biopsy 5 days prior to death 
failure showed hepatocyte swelling, 
Alive 
suggesting hepatitis; no rejec-
tion 
Obstructed cholecystojejunostomy to Biliary obstruction, intrahepatic 
choledochajejunostomy; subse- sludge and cholangitis; no rejec-
Quent rupture of mycotic hepatic ar- tion 
tery aneurysm into jejunum 
Pneumococcal meningitis; liver failure; Chronic rejection 
liver abscesses 
Cholecystojejunostomy to choledocho- Chronic rejection; massive liver ne-
jejunostomy; liver failure crasis 
Leak of colonic anastomosis after Chronic cholangitis; no rejection 
emergency colectomy; liver and pul-
monary failure; CMV infection 
Chicken pox; fresh portal vein throm-
basis 
Pulmonary sepSis 
Hepatitis group viruses seen by EM 
in necrotic tissue and in some of 
the adjacent cells 
Biopsy on the 15th day showed no 
rejection 
within 10 days after transplantation was 
observed only in two cases (OT 71A and OT 
168). The liver pathology of the first case (OT 
71A) on the tenth posttransplant day revealed 
acute rejection of a cellular and humoral 
nature, and this could be interpreted at most 
as a modified type of hyperacute rejection in 
liver homograft. The second case (OT 168) 
had significant periopcrative ischemic dam-
Table 2. ImmunOlogic Profile 
Nonspecific Cytotoxic 
Blood HLA-A.B Donor-Specific 
Antibody Screening 
(% of Panel Cells) 
Type Mismatch Cytotoxic Antibody 
(Donor to Recipient) Number (Standard C,ossmatch) T-Warm B-Warm B-Cold 
OT 58 OtoO 4 Pos. (1:2) 3 43 6 
OT 63 OtoO 3 Pos. (1 :64) 76 100 0 
OT 71 A OtoA 2 Pos. (1: 16) 23 96 3 
OT 101 OtoO 4 Pos. (7) 84 100 0 
OT 114 OtoA 3 Pos. (7) 88 96 0 
OT 119 OtoO 4 Pos. (7) 92 100 0 
OT 122 OtoA 2 Pos. (7) 84 100 0 
OT 1038 OtoA 3 Pos. (7) 0 3 0 
OT 138 OtoA 3 Pos. (1:4) 15 31 D 
OT 151 AtoA 4 Pos. (1:8) 3 43 3 
OT 168 OtoO Pos. (1 :64)* 100 100 0 
* Positive T-warm and 8-warm. 
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age to the graft, but the graft produced bile 
on immediate posttransplant days. The liver 
biopsy obtained on the 15th posttransplant 
day did not show any rejection of either a 
cellular or humoral nature. 
The remaining nine patients did not have 
early graft dysfunction, and one (OT 114) is 
still alive and well over 4 years after trans-
plantation. Two (OT 58 and OT 103B) lived 
more than a year. The liver pathology of these 
nine patients did not show acute rejection 
(Table 1). 
DISCUSSION 
The pathophysiology of hyperacute rejec-
tion has been well studied in recent years. 
Fixation of antibody to the graft is apparently 
the initial event followed by entrapment of 
clotting factors and formed blood elements in 
the microvasculature of the graft and conse-
quent graft necrosis. The antibodies that are 
known to cause hyperacute rejection in kidney 
allografts are anti-A and -B red cell isoagglu-
tinins 4 and cytotoxins against T lympho-
cytes. 3,5,6 Heterospccific antibody in the het-
erograft system can also have the same 
effect.7 Accumulated clinical and experimen-
tal evidence indicates that kidney grafts are 
unusually prone to the irreversible conse-
quences of hyperacute rejection and that the 
liver graft, in contrast, is unusually resis-
tant. 1,2,7 The difference in microvascular 
structure between the kidney and the liver 
(capillary versus sinusoidal system) may be 
responsible. 
We have previously reported ten patients 
who did not have hyperacute rejection of liver 
grafts in spite of the detection in their sera by 
standard cytotoxicity testing of antibody 
against the specific donor. I ,2 With recent 
advances in transplantation serology, it is now 
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known that anti-T-lymphocyte antibody is 
responsible for hyperacute rejection, but that 
anti-B-Iymphocyte antibody is not responsi-
ble. 3,6 As the donor lymphocytes were no 
longer available in the previous ten cases, the 
sera were tested for anti-T - and anti- B-
lymphocyte toxicity against a random lym-
phocyte panel. In retrospect, five of the 
patients who did not possess warm anti-T 
antibodies were not at risk from hyperacute 
rejection. However, five (OT 63, OT 101, OT 
114,OT 119, and OT 122) of ten patients had 
strong and wide (greater than 75% of panel 
cells) anti-T-lymphocyte antibody. 
It is reasonable to conclude from this infor-
mation that at least some of these five 
patients had anti-T-lymphocyte antibody 
against the donor, but did not reject liver 
homografts hyperacutely. One (OT 114) of 
the five patients is still alive and well with 
normal liver function over 4 years after trans-
plant. In the additional recent case (OT 168) 
such speculation is not necessary. The liver 
transplant was known to have been performed 
in the presence of strong cytotoxic antibody 
against the donor T lymphocytes. The liver 
homograft did not undergo hyperacute rejec-
tion and the biopsy on the 15th day did not 
show any sign of rejection, either of humoral 
or of cellular type, 
CONCLUSION 
The data presented above are consistent 
with previous reports that the liver is unusu-
ally resistant to hyperacute rejection and that 
a positive anti-T-lymphocyte crossmatch is 
not an absolute contraindication for liver 
homotransplantation. Further investigations 
are needed to explain the unusual resistance 
of the liver to hyperacute rejection. 
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